-DOCSTART- -X- O
In -X- _ O
recent -X- _ O
years -X- _ O
, -X- _ O
the -X- _ O
within-host -X- _ O
viral -X- _ O
dynamics -X- _ O
of -X- _ O
dengue -X- _ B-Patient
infections -X- _ I-Patient
have -X- _ O
been -X- _ O
increasingly -X- _ O
characterized -X- _ O
, -X- _ O
and -X- _ O
the -X- _ O
relationship -X- _ O
between -X- _ O
aspects -X- _ O
of -X- _ O
these -X- _ O
dynamics -X- _ O
and -X- _ O
the -X- _ O
manifestation -X- _ O
of -X- _ O
severe -X- _ O
disease -X- _ O
has -X- _ O
been -X- _ O
increasingly -X- _ O
probed. -X- _ O
Despite -X- _ O
this -X- _ O
progress -X- _ O
, -X- _ O
there -X- _ O
are -X- _ O
few -X- _ O
mathematical -X- _ O
models -X- _ O
of -X- _ O
within-host -X- _ B-Intervention
dengue -X- _ I-Intervention
dynamics -X- _ I-Intervention
, -X- _ O
and -X- _ O
the -X- _ O
ones -X- _ O
that -X- _ O
exist -X- _ O
focus -X- _ O
primarily -X- _ O
on -X- _ O
the -X- _ O
general -X- _ B-Comparison
role -X- _ I-Comparison
of -X- _ I-Comparison
immune -X- _ I-Comparison
cells -X- _ I-Comparison
in -X- _ I-Comparison
the -X- _ I-Comparison
clearance -X- _ I-Comparison
of -X- _ I-Comparison
infected -X- _ I-Comparison
cells -X- _ I-Comparison
, -X- _ O
while -X- _ B-Comparison
neglecting -X- _ I-Comparison
other -X- _ I-Comparison
components -X- _ I-Comparison
of -X- _ I-Comparison
the -X- _ I-Comparison
immune -X- _ I-Comparison
response -X- _ I-Comparison
in -X- _ I-Comparison
limiting -X- _ I-Comparison
viraemia. -X- _ I-Comparison
Here -X- _ O
, -X- _ O
by -X- _ O
considering -X- _ O
a -X- _ O
suite -X- _ O
of -X- _ O
mathematical -X- _ O
within-host -X- _ O
dengue -X- _ O
models -X- _ O
of -X- _ O
increasing -X- _ O
complexity -X- _ O
, -X- _ O
we -X- _ O
aim -X- _ O
to -X- _ O
isolate -X- _ O
the -X- _ O
critical -X- _ O
components -X- _ O
of -X- _ O
the -X- _ O
innate -X- _ O
and -X- _ O
the -X- _ O
adaptive -X- _ O
immune -X- _ O
response -X- _ O
that -X- _ O
suffice -X- _ O
in -X- _ O
the -X- _ O
reproduction -X- _ O
of -X- _ O
several -X- _ O
well-characterized -X- _ O
features -X- _ O
of -X- _ O
primary -X- _ O
and -X- _ O
secondary -X- _ O
dengue -X- _ B-Patient
infections. -X- _ I-Patient
By -X- _ O
building -X- _ O
up -X- _ O
from -X- _ O
a -X- _ O
simple -X- _ O
target -X- _ O
cell -X- _ O
limited -X- _ O
model -X- _ O
, -X- _ O
we -X- _ O
show -X- _ O
that -X- _ O
only -X- _ O
the -X- _ O
innate -X- _ O
immune -X- _ O
response -X- _ O
is -X- _ O
needed -X- _ O
to -X- _ O
recover -X- _ O
the -X- _ B-Outcome
characteristic -X- _ I-Outcome
features -X- _ I-Outcome
of -X- _ I-Outcome
a -X- _ I-Outcome
primary -X- _ I-Outcome
symptomatic -X- _ I-Outcome
dengue -X- _ I-Outcome
infection -X- _ I-Outcome
, -X- _ O
while -X- _ O
a -X- _ O
higher -X- _ O
rate -X- _ O
of -X- _ O
viral -X- _ O
infectivity -X- _ O
( -X- _ O
indicative -X- _ O
of -X- _ O
antibody-dependent -X- _ O
enhancement -X- _ O
) -X- _ O
and -X- _ O
infected -X- _ O
cell -X- _ O
clearance -X- _ O
by -X- _ O
T -X- _ O
cells -X- _ O
are -X- _ O
further -X- _ O
needed -X- _ O
to -X- _ O
recover -X- _ O
the -X- _ B-Outcome
characteristic -X- _ I-Outcome
features -X- _ I-Outcome
of -X- _ I-Outcome
a -X- _ I-Outcome
secondary -X- _ I-Outcome
dengue -X- _ I-Outcome
infection. -X- _ I-Outcome
We -X- _ O
show -X- _ O
that -X- _ O
these -X- _ O
minimal -X- _ O
models -X- _ O
can -X- _ O
reproduce -X- _ O
the -X- _ B-Outcome
increased -X- _ I-Outcome
risk -X- _ I-Outcome
of -X- _ I-Outcome
disease -X- _ I-Outcome
associated -X- _ I-Outcome
with -X- _ I-Outcome
secondary -X- _ I-Outcome
heterologous -X- _ I-Outcome
infections -X- _ I-Outcome
that -X- _ O
arises -X- _ O
as -X- _ O
a -X- _ O
result -X- _ O
of -X- _ O
a -X- _ O
cytokine -X- _ O
storm -X- _ O
, -X- _ O
and -X- _ O
, -X- _ O
further -X- _ O
, -X- _ O
that -X- _ O
they -X- _ O
are -X- _ O
consistent -X- _ O
with -X- _ O
virological -X- _ O
indicators -X- _ O
that -X- _ O
predict -X- _ O
the -X- _ O
onset -X- _ O
of -X- _ O
severe -X- _ O
disease -X- _ O
, -X- _ O
such -X- _ O
as -X- _ O
the -X- _ O
magnitude -X- _ O
of -X- _ O
peak -X- _ O
viraemia -X- _ O
, -X- _ O
time -X- _ O
to -X- _ O
peak -X- _ O
viral -X- _ O
load -X- _ O
, -X- _ O
and -X- _ O
viral -X- _ O
clearance -X- _ O
rate. -X- _ O
Finally -X- _ O
, -X- _ O
we -X- _ O
show -X- _ O
that -X- _ O
the -X- _ B-Outcome
effectiveness -X- _ I-Outcome
of -X- _ I-Outcome
these -X- _ I-Outcome
virological -X- _ I-Outcome
indicators -X- _ I-Outcome
to -X- _ I-Outcome
predict -X- _ I-Outcome
the -X- _ I-Outcome
onset -X- _ I-Outcome
of -X- _ I-Outcome
severe -X- _ I-Outcome
disease -X- _ I-Outcome
depends -X- _ O
on -X- _ O
the -X- _ O
contribution -X- _ O
of -X- _ O
T -X- _ O
cells -X- _ O
in -X- _ O
fuelling -X- _ O
the -X- _ O
cytokine -X- _ O
storm -X- _ O
. -X- _ O

